Suppr超能文献

移植肾功能正常的患者心脏手术后结局较差。

Inferior outcomes following cardiac surgery in patients with a functioning renal allograft.

机构信息

Department of Cardiothoracic Surgery, Royal Papworth Hospital, Cambridge, UK.

出版信息

Interact Cardiovasc Thorac Surg. 2021 Jan 22;32(2):174-181. doi: 10.1093/icvts/ivaa245.

Abstract

OBJECTIVES

Renal transplantation is an effective treatment for end-stage renal failure. The aim of this study was to evaluate outcomes for these patients undergoing cardiac surgery.

METHODS

A retrospective analysis identified patients with a functioning renal allograft at the time of surgery. A 2:1 propensity matching was performed. Patients were matched on: age, sex, left ventricle function, body mass index, preoperative creatinine, operation priority, operation category and logistic EuroSCORE.

RESULTS

Thirty-eight patients undergoing surgery with a functioning renal allograft were identified. The mean age was 62.4 years and 66% were male. A total of 44.7% underwent coronary artery bypass grafting and 26.3% underwent a single valve procedure. The mean logistic EuroSCORE was 10.65. The control population of 76 patients was well matched. Patients undergoing surgery following renal transplantation had a prolonged length of intensive care unit (3.19 vs 1.02 days, P < 0.001) and hospital stay (10.3 vs 7.17 days, P = 0.05). There was a higher in-hospital mortality (15.8% vs 1.3%, P = 0.0027). Longer-term survival on Kaplan-Meier analysis was also inferior (P < 0.001). One-year survival was 78.9% vs 96.1% and 5-year survival was 63.2% vs 90.8%. A further subpopulation of 11 patients with a failed renal allograft was identified and excluded from the main analysis; we report demographic and outcome data for them.

CONCLUSIONS

Patients with a functioning renal allograft are at higher risk of perioperative mortality and inferior long-term survival following cardiac surgery. Patients in this population should be appropriately informed at the time of consent and should be managed cautiously in the perioperative period with the aim of reducing morbidity and mortality.

摘要

目的

肾移植是治疗终末期肾衰竭的有效方法。本研究旨在评估这些患者接受心脏手术的结果。

方法

回顾性分析确定了手术时具有功能肾移植的患者。采用 2:1 倾向匹配。对患者进行了匹配:年龄、性别、左心室功能、体重指数、术前肌酐、手术优先级、手术类别和逻辑 EuroSCORE。

结果

共确定了 38 例接受有功能肾移植手术的患者。平均年龄为 62.4 岁,66%为男性。44.7%接受了冠状动脉旁路移植术,26.3%接受了单一瓣膜手术。平均逻辑 EuroSCORE 为 10.65。对照组 76 例患者匹配良好。肾移植后接受手术的患者在重症监护病房(3.19 天 vs 1.02 天,P<0.001)和住院时间(10.3 天 vs 7.17 天,P=0.05)方面均较长。住院死亡率较高(15.8% vs 1.3%,P=0.0027)。在 Kaplan-Meier 分析中,长期生存率也较差(P<0.001)。1 年生存率为 78.9% vs 96.1%,5 年生存率为 63.2% vs 90.8%。进一步确定了 11 例肾功能衰竭患者的亚组,并从主要分析中排除;我们报告了他们的人口统计学和结果数据。

结论

具有功能肾移植的患者在接受心脏手术后围手术期死亡率更高,长期生存预后更差。在获得知情同意时,应向该人群的患者提供适当的信息,并在围手术期谨慎管理,以降低发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aea8/8906761/11da7fdcad14/ivaa245f2.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验